PAUL SCHIMMEL - 26 Apr 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
/s/ Nancy E. Denyes, attorney-in-fact
Issuer symbol
LIFE
Transactions as of
26 Apr 2023
Net transactions value
$0
Form type
4
Filing time
28 Apr 2023, 16:54:12 UTC
Previous filing
28 Apr 2022
Next filing
11 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common stock Options Exercise +6,000 +208% 8,890 26 Apr 2023 Direct F1, F2
holding LIFE Common stock 113,023 26 Apr 2023 See Footnote F3
holding LIFE Common stock 679,143 26 Apr 2023 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Restricted Stock Unit Options Exercise $0 -6,000 -100% $0.000000* 0 26 Apr 2023 Common Stock 6,000 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
F2 RSUs convert into common stock on a one-for-one basis.
F3 These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.
F4 These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
F5 The RSUs fully vested one year from the grant date which was April 26, 2022.